Detection and treatment of triple negative breast cancer: development of novel nanomedicine devices allowing simultaneous molecular imaging, gene therapy and aptamer therapy (2014-2016)
Experts
Professor
Kristofer Thurecht
Senior Group Leader and Deputy Director, Research (AIBN/CAI)
Australian Institute for Bioengineering and Nanotechnology